Insight

An update on the development of HER2-targeted therapies

Photo taken from ghealth121.com

Jul 25, 2024, 01:39

An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:

“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”

HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology

Autors: Jeesun Yoon and Do-Youn Oh

HER2-targeted

Source: Elisabetta Bonzano/X

Breast Cancer cancer Do-Youn Oh Elisabetta Bonzano HER2-targeted therapy Jeesun Yoon Nature Reviews Clinical Oncology OncoDaily Oncology radiation oncology

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology